Humana: Continued Growth Underpinned by Medicare Advantage Plans By Ivo Kolchev Quantitative Analysis Read More
McKesson: Continued Top and Bottom-line Growth Driven by North America By Ivo Kolchev Quantitative Analysis Read More
Pfizer: Earnings Trough in 2023 as COVID-19 Becomes Endemic By Ivo Kolchev Quantitative Analysis Read More
Booz Allen Hamilton: On Track to Meet 2025 Targets on Organic Strength Coupled with Selective M&A By Ivo Kolchev Quantitative Analysis Read More
